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Summary 
We analyzed at clonal level the functional profile of  circulating or skin-infiltrating T lymphocytes 
from two individuals infected with the human immunodeficiency  virus type 1 (HIV-1), suffering 
from a Job's-like syndrome (eczematous dermatitis, recurrent skin and sinopulmonary infections, 
and hypergammaglobulinemia  E) and showing virtually no circulating  CD4 + T cells. Most of 
the CD3 + T cell clones generated from both patients were CD4- CD8 + TCRc~/3  +  . The others 
were  CD4-  CD8-  TCRc~B  +  which  exhibited  reduced  mRNA  expression  for  the  CD8 
molecule or no mRNA expression for either CD4 or CD8 molecules. The great majority of 
both CD4- CD8 + and CD4- CD8- did not produce interferon (IFN) 3/and exhibited reduced 
cytolytic activity. Rather, most of them produced large amounts of both interleukin (IL) 4 and 
IL-5 and provided B cell helper function for IgE synthesis. These data suggest  that a switch 
of cytolytic CD8 + T cells showing a Thl-like cytokine secretion profile to cells that make Th2- 
type cytokines, exhibit reduced cytolytic potential,  and provide B cell helper function can occur 
in the course of HIV-1 infection. These cells may contribute to the reduced defense against viral 
infections and intracellular parasites and account for the elevated IgE serum levels, eosinophilia, 
and the allergic-like clinical manifestations seen in a proportion of HIV-l-infected individuals. 
C 
D8  T cells are a major defense against viral infections 
and intracellular parasites, as their production of IFN-3' 
and TNF-~, as well as their cytolytic activity, are key ele- 
ments in the immune response to these pathogens (1, 2). Re- 
cently, however, it was shown that the cytokine profile of 
CD8 + T cell clones derived from patients with lepromatous 
leprosy was characterized by high levels of IL-4. These clones 
were similar  to murine and human CD4 + Th2  cells and 
were designed type 2 CD8 + cells (3). Furthermore, it has 
been reported that murine CD8 + T  cells can be primed in 
vitro to produce IL-4 (4), and when activated in vitro in the 
presence of IL-4, can switch development to a CD8- CD4- 
Th2-1ike phenotype that is not cytolytic and that does not 
produce IFN-3, (5). 
In this report we have examined the functional profile of 
circulating and skin-infiltrating T lymphocytes from two HW- 
infected individuals suffering from a Job's-like syndrome (as- 
sociation of eczematous dermatitis,  otitis,  and sinopulmo- 
nary infections with recurrent skin lesions and hypergam- 
maglobulinemia E) (6-10),  showing very low numbers of 
CD4 + circulating T lymphocytes (<50/#1 of blood). Anal- 
ysis at clonal level revealed that in both patients,  virtually 
all CD8 + circulating  T lymphocytes had switched in vivo 
from the production of Thl-type cytokine IFN-7 to  the 
production of Th2-type cytokines,  IL-4,  IL-5,  and IL-10. 
Moreover,  high  proportions  of Th2-type  CD4-  CD8- 
TCRoe~8  + cells that expressed reduced mRNA encoding for 
the CD8 molecule or no mRNA encoding for either CD4 
or CD8  molecules  were found.  Both  CD4-  CD8 + and 
CD4- CD8- Th2-1ike clones showed poor cytolytic activity 
and provided B cell helper function for IgE synthesis. 
Materials and Methods 
Patients.  The study was performed  in four HIV-l-infected  pa- 
tients and two HIV-l-seronegative  healthy volunteers. According 
to the Centers for Disease Control (Atlanta, GA) criteria  (11), two 
of the patients were  dassified in the Group IV Subgroup C-1 be- 
cause they had suffered  from Pneumocystis carinii and Toxoplasma 
gondiinfection, respectively:  one in the Group IV Subgroup  D (Ka- 
posi's sarcoma),  and one in the Group IV Subgroup C-2 (oral leu- 
kopachia  and candidiasis). Two of  the four HIV-l-infected  patients 
also had a  Job's-like syndrome  (recurrent  skin lesions  caused  by Staph- 
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didiasis, and staphylococcal  subcutaneous "cold abscesses"). Both 
patients had high serum IgE levels (7,700 and 3,100 U/ml, respec- 
tively) and hypereosinophilia (absolute eosinophil counts 900 and 
1,500 cells/#l, respectively). They were anamnestically free of his- 
tories  of allergic  diseases or  atopic  dermatitis  and  never  had 
documented staphylococcal  infections before their seroconversion 
to HIV-1. None of them had detectable parasitic infestations.  The 
other  two  HIV-l-infected patients,  as  well  as  the  two  HIV- 
1-seronegative healthy individuals,  had normal serum IgE levels 
(<100 U/ml) and normal values of circulating eosinophils  (<150 
cells/#1).  Immunopbenotyping of PBMC by flow cytometry re- 
vealed very low levels of CD4* T cells (<50/#1) in all four HIV- 
1-infected patients but normal values in the two HIV-l-seronega- 
rive subjects (1,200 and 1,150 cells/#l, respectively). Absolute values 
of CD8 + T cells were within normal range (350-600 cells/#l) in 
both HIV-l-infected patients and healthy subjects. All patients and 
controls gave informed consent for the studies. 
Reagents.  PHA was purchased from GIBCO BKL (Gaithers- 
burg, MD) and PMA from Sigma Chemical Co. (St. Louis, MO). 
Recombinant I1.2 was  a kind gift of Eurocetus (Milan,  Italy). 
Recombinant I1.5  and -10 were purchased from Amersham In- 
ternational (Amersham, Bucks, UK) and Genzyme Corp. (Cam- 
bridge, MA), respectively. Anti-CD3, -CD4, -CD8, and-c~/$TCK 
mAb were purchased from Becton Dickinson & Co. (Mountain 
View, CA). 
T Cell Cloning System.  PBMC were obtained from the four 
HIV-l-infected patients  and  the  two HIV-seronegative healthy 
volunteers by the Ficoll-Hypaque gradient centrifugation technique, 
and T cells cloned according to a previously described technique 
that allows the clonal expansion of virtually every T cell regardless 
of its antigen specificity (12, 13). Briefly, PBMC were seeded under 
limiting dilution conditions (0.3 cells/well)  in round-bottomed 
microwells  containing  1@  irradiated  allogeneic spleen  cells  (as 
feeder cells) and PHA (1% vol/vol) in a final volume of 0.2 ml 
R.PMI 1640 medium supplemented with 2 mM t-glutamine, 2  x 
10 -s M 2-ME (complete medium) containing human recombinant 
I1,2 (20 U/ml) and 10% FCS (Hyctone Laboratories, Logan, UT). 
Growing microcultures were then supplemented at weekly intervals 
with II.2 (20 U/ml) and 10  s irradiated feeder cells. 
In two HIV-infected patients (one without and one with Job- 
like syndrome) T  cell clones were also derived from skin biopsy 
specimens.  To this end, biopsy specimens  were cultured in com- 
plete medium, supplemented with I1.2 (50 U/ml) three times a 
week, and cultures continued for an additional 9 d. Tissue speci- 
mens were then disrupted and viable T blasts resuspended in I1, 
2-supplemented medium for an additional 3 d. To generate T cell 
clones, T blasts were seeded under limiting conditions with PHA, 
feeder cells, and I1.2,  as described above. 
Immunophenotyping oft Cell Clones.  Cell surface marker anal- 
ysis  of T  cell  clones  was  performed  on  a  Cytoron  Absolute 
cytofluorimeter (Ortho Pharmaceuticals,  Raritan,  NJ) by using 
fluoresceinated  or phycoerythrinated anti-CD3, -CD4, -CD8, or 
-cx/3TCK,  as described  (14). 
T cell clones lacking both CD4 and CD8 on their surface were 
analyzed for the expression  of CD4 and CD8 mRNA by PCR 
technology, as described (15). To this end, total cellular KNA was 
prepared from cells by a single step guanidium isothiocyanate-phenol- 
cloroform extraction method. The first strand cDNA was synthe- 
sized using 4 #g total KNA, reverse transcriptase (Moloney mu- 
rine leukemia virus [M-MLV]; GIBCO BRL) and oligodT primer 
(Pharmacia,  Uppsala,  Sweden) in a final volume of 40 #1 at 37~ 
for 1 h. The products thus obtained were denaturated and 5 #1 
were utilized in the amplification reaction with specific primers 
for CD4 and CD8 molecules (Clontech Laboratories,  Palo Alto, 
CA). The PCK amplification was carried out with 2.5 Taq poly- 
merase (Perkin Elmer Cetus, Norwalk, CT) and 500 pmol of each 
primer, and consisted of 30 cycles followed by a 15-min final exten- 
sion at 72~  The amplified products were run on a 1.8% agarose 
gel, as described (15). 
Table  1.  Surface Phenotype of T  Cell Clones Derived  from HIV-I-infected Patients with Job's-like Syndrome* 
Absolute numbers of 
circulating T  cells (x  109/liter) 
No.  and phenotype of 
clones obtained 
Source of T  ceils  CD4+CD8 -  CD8§  -  CD4§  -  CD4-CD8 §  CD4-CD8- 
HIV-l-seronegative 
Healthy  1.2  0.7 
Healthy  1.1  0.5 
HIV-l-seropositive 
Group IV-C1  ~0.1  0.6 
Group IV-D  <~0.1  0.4 
Skin biopsy 
Group IV-C1  and 
Job's-like syndrome  <(0.I  0.7 
Group IV-C-2 and 
Job's-like syndrome  (0.1  0.3 
Skin biopsy 
58  32  0 
68  36  0 
2  22  0 
1  27  1 
3  35  0 
3  37  18 
0  40  11 
1  25  5 
* Analysis of the surface phenotype in both fresh circulating T cells and T cell clones was performed on a cytofluorimeter with fluoresceinated  anti- 
CD4 and phycoerythrinated anti-CD8 mAb. 
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secretion profile of T cell clones was evaluated by stimulating 106 
T cell blasts from each clone in 1 ml complete medium with PMA 
plus anti-CD3 Ab, as reported elsewhere  (14--16). After 24 h, cul- 
ture supernatants were collected and stored at  -70~  until used. 
The quantitative determination of IFN-3, and IL-4 was performed 
by a commercial ILIA (Centocor Inc., Malvern, PA) and a com- 
mercial ELISA (British Biotechnology, Oxon, UK), respectively. 
IL-5 and -10 were quantified by in-house-made capture ELISAs using 
anti-Ib5 or -IL-10  mAb bound to microwell plates and biotinylated 
anti-IL-5 or -IL-10  mAbs (Pharmingen, San Diego, CA) as revealing 
antibodies,  respectively. T call done supernatants showing IFN-% 
Ib4, -5, or -10 levels 5 SD over the mean levels in control superna- 
tants derived from irradiated feeder cells alone were regarded as 
positive. 
Cytolytic activity of T ceU clones was assessed as reported rise- 
where (14, 16). Briefly, T  cell blasts  of each clone were washed 
three times,  counted, resuspended in complete medium,  and as- 
sayed for cytolytic activity against  murine SlCr P815 mastocytoma 
ceUs in the presence of PHA (1% vol/vol) (lectin-dependent assay) 
or anti-CD3 mAb (100 #g/m1) (redirected system) with an E/T 
ratio of 1:1. After 4 h at 37~  0.1 ml supernatant was removed 
for measurement of StCr release  (14, 16). 
B cell helper activity for IgE synthesis by T cell clones was evalu- 
ated as detailed elsewhere (14). Briefly, 10  s T call blasts from each 
clone were stimulated for 6 h with anti-CD3 mAb and then cocul- 
tured for 7 d with  10  s purified allogeneic B cells. The quantita- 
tive determination of IgE in the supernatant was performed by an 
appropriate RIA (14). 
l~eSil|tS 
T  Cell Clones Generated from HIV-1-infected Subjects with 
Job's-like Syndrome Are CD4-  CD8 + or CD4-  CD8-.  All 
clones derived from both HIV-l-infected patients and HIV- 
1-seronegative  individuals  were  CD3 +  TCRol3 +.  As  ex- 
pected, the majority of CD3 + T  cell clones derived from the 
two  HIV-l-seronegative  individuals  were  CD4 +,  the  re- 
maining  being  CD8 +  with  a  CD4/CD8  ratio  (1.7-1.9) 
comparable with  that  found between the two main T  cell 
subsets in freshly prepared blood suspensions (1.7-2.2) (Table 
1).  This suggests  that because of the high efficiency of the 
cloning technique (>70%),  no significant loss of one or an- 
other subset had occurred during the cloning procedure. In 
Figure 1.  Immunophenotyping of T call clones derived from the peripheral  blood of a HIV-infected  patient with Job's-like syndrome. (Left)  Surface 
CD4 and CD8 expression  determined in six clones (A-F) with flow cytometry after staining with fluorescein-conjugated  anti-CD4 and PE-hbeled 
anti-CD8 mAbs. Clones A and B are CD4-CD8 +, whereas the other four clones are CD4-CD8-.  (Right) PCR analysis on the same clones (A-F) 
and on a CD4+CD8- done (G) ofmRNA for CD4 (primer 1: nucleotides 1009-1032, sense strand; primer 2: nucleotides 1419-1446, antisense  strand; 
379 bp) and CD8 (primer 1: nucleotides 776-804, sense strand; primer 2: nucleotides 1126-1154, antisense strand; 438 bp). 
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four HIV-l-infected patients (showing numbers of circulating 
CD4 + T cells <20/#1) were CD4 +. The great majority of 
clones were CD8 +, but in the two HIV-infected patients 
with the Job's-like syndrome, noticeable proportions of them 
expressed neither the CD4 nor the CD8 phenotype. Simi- 
larly, virtually all clones derived from the skin biopsy spec- 
imen of one of the two patients with Job's-like  syndrome 
displayed the CD8 + CD4-  or the CD8-  CD4-  phenotype. 
In contrast, in the other two HIV-1-infected patients, virtu- 
ally  all  clones  obtained  from  either  blood  or  skin  were 
CD8 +  (Table  1). 
To  establish  the  nature  of CD4-  CDS-  clones  derived 
from the two HIV-l-seropositive subjects suffering from the 
Job's-like syndrome, the expression of mRNA for both CD4 
and CD8 molecules was evaluated by amplification with PCR. 
None of the CD4-  CD8-  clones expressed mRNA for the 
CD4 molecule. The great majority of them showed a reduced 
mKNA expression for the CD8 molecule and a minority ap- 
parently did not show mKNA expression for either the CD4 
or the  CD8  molecule (Fig.  1). 
C1M-  CD8 § and CD4-  CD8-  T Cell Clones Show a Th2- 
like Cytokine Profil~  All CD4-  dones from both HIV-l-in- 
fected patients and HIV-l-seronegative healthy subjects were 
then assessed for their  cytokine secretion profile after  24-h 
stimulation with PMA plus anti-CD3 mAb. Clones producing 
IFN-3,, but no IL-4 or IL-5, were classified  as Thl-type, those 
Table  2.  Cytokine  Secretion Profile of CD4-  T  Cell 
Clones Derived  from HIV-l-infected Patients 
with a Job's-like Syndrome* 
Diagnosis 
CD8 §  CD8- 
Thl  Th0  Th2  Thl  Th0  Th2 
HIV-l-seronegative 
Healthy  28  4  0  0  0  0 
Healthy  31  5  0  0  0  0 
HIV-l-seropositive 
Group IV-C1  18  3  1  0  0  0 
Group IV-D  23  2  2  0  1  0 
Skin biopsy  16  14  5  0  0  0 
Group IV-C1 and 
Job's-like-syndrome  2  6  29  0  2  16 
Group IV-C2 and 
Job's-like syndrome  6  10  24  1  4  6 
Skin biopsy  0  2  23  0  0  5 
* T cell clones were stimulated for 24 h with PMA plus anti-CD3 mAb 
and indicated cytokines measured in their supematants. T cell clones 
producing IFN-~/but neither IL-4 nor IL-5 were defined as Thl; T cell 
clones producing IL-4 and/or IL-5 but not IFN-'y were defined as Th2; 
T cell clones producing IFN-y and IL-4 or IL-5 or all three cytokines 
were defined as Th0. 
producing IL-4 and IL-5, but  no IFN-'y were classified as 
Th2-type, and those showing a mixed cytokine secretion profile 
were classified as Th0-type (17). The results of these experi- 
ments are summarized in Tables 2 and 3. As expected, virtu- 
ally all CD4-  CD8 + clones derived from HIV-l-seronega- 
tive healthy individuals produced IFN-3,, but no IL-4,  -5, 
or -10 (Thl-type). Similarly,  the great majority of CD4- 
CD8 + clones from the two HIV-infected patients who did 
not suffer from the Job's-like syndrome exhibited a Thl-type 
profile.  In contrast, virtually all CD4-  CD8 + and CD4- 
CD8- clones derived from the two HIV-l-infected patients 
with Job's-like  syndrome produced IL-4,  -5, and -10, thus 
exhibiting an opposite (Th2-type) profile. Similarly, the great 
majority of both CD4-CD8 + and CD4-  CD8-  clones de- 
rived from the skin of the patient with Job's-like syndrome 
were Th2. In contrast, the majority of CD4-  CD8 + clones 
derived from the skin of the patient with Kaposi's sarcoma 
were Thl. However,  even in the skin of this patient, high 
proportions of clones producing IL-4 in addition to IFN-y 
(Th0) or IL-4 alone (Th2) were found (Table 2). 
CD4- CD8 + and CIM-  CD8-  T Cell Clones Exhibit Re- 
duced Cytolytic Activity  and Provide B  Cell Helper Function. 
Cytolytic activity and B cell helper function for IgE synthesis 
Table  3.  Cytokine  Secretion Profile of Some Representative 
CD4-  T  Cell Clones from HIV-l-infected 
Patients with a Job's-like syndrome 
Cytokine produced* 
Cell surface 
T  cell clone donor  phenotype  IFN--y  IL-4  IL-5  IL-IO 
HIV-l-seronegative 
HIV-l-seropositive 
with Job's-like 
syndrome 
ng/ml 
CD8 +  15.5  <0.1  <0.5  <0.5 
CD8 +  2.5  <0.1  <0.5  <0.5 
CD8 +  9.4  <0.1  <0.5  0.7 
CD8 +  7.0  <0.1  <0.5  <0.5 
CD8 +  13.1  <0.1  <0.5  <0.5 
CD8+  <0.5  4.7  9.0  0.7 
CD8 +  <0.5  4.6  9.2  3.4 
CD8 +  <0.5  2.3  3.3  <0.5 
CD8 +  <0.5  4.7  1.9  1.3 
CD8 +  -<0.5  1.8  1.5  0.7 
CD8-  <0.5  2.0  1.7  0.6 
CD8-  <0.5  1.4  9.2  3.2 
CD8-  <0.5  4.5  8.5  0.9 
" 106 T cell blasts from each clone were stimulated for 24 h with PMA 
plus anti-CD3 mAb and indicated cytokines measured in supernatants 
by appropriate KIA and ELISA, as reported in Materials and Methods. 
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from the four HIV-l-infected patients and in eight of the 
two HIV-l-seronegative healthy controls. The great majority 
of CD4-  CD8 + clones from the two HIV-l-infected pa- 
tients with the Job's-like syndrome, showing the Th2-type 
cytokine secretion profile, exhibited significantly reduced (p 
<0.01)  lectin-dependent or redirected cytolytic activity in 
comparison with  CD4-  CD8 +  clones from both  HIV- 
1-seronegative individuals and HIV-l-seropositive patients 
without the Job's-like syndrome and showing a Thl-like 
phenotype. Furthermore, after stimulation with anti-CD3 
mAb, they all provided helper function for IgE synthesis in 
normal B cells, whereas none of the Thl-type CD8 + clones 
derived from the other patients or controls did. Table 4 shows 
the results obtained with 14 representative clones. 
Table 4.  Cytolytic Activity and B Cell Helper Function  for IgE 
Synthesis of Some Representative CD4-  T  Cell Clones  from 
the 1-1111-1-infected  Patients with a Job's-lilce Syndrome 
Cell surface  Cytolytic  Helper 
and cytokine  activity  Function 
T cell clone  secretion  (percent s~Ctk  for IgE 
donor  profile*  release +  SE)*  synthesisS 
HIV-l-seronegative 
HIV-l-seropositive 
with Job's-like 
syndrome 
,g/ml 
CD8 + Thl  60 _+ 5  <0.1 
CD8 § Thl  55  _+ 4  (0.1 
CD8 § Thl  65  _+ 3  (0.1 
CD8 § Thl  85  _+ 7  (0.1 
CD8 § Thl  48  _+ 5  (0.1 
CD8 ~ Thl  75 _+ 6  ~0.1 
CD8*  Th2  37  +_  4  7.2 
CD8 + Th2  34  +_  3  3.5 
CD8 +  Th2  25  +  4  5.3 
CD8 + Th2  45  +  4  2.1 
CD8 §  Th2  42  _+  3  6.3 
CD8-  Th2  22  _+  2  4.8 
CD8-  Th2  23  _+ 3  7.2 
CDS-  Th2  17 +  2  3.1 
" Cell surface  phenotype was  evaluated  as  reported  in  the legend of 
Table 1. Cytokine secretion profile was defined as reported in the legend 
to Table 1. 
5  x  103 effector ceils were incubated  in triplicate  with 5  x  103 stCr- 
labeled P815 mastocytoma cells for 4 h at 37~  in the presence of PHA 
(1% vol/vol). The slCr release was calculated as described  (14). 
S 103 T  cell blasts were activated  for 6 h with anti-CD3 mAb and in- 
cubated  for 10 d with 10  s purified  allogeneic  B cells. IgE protein was 
measured  in the supernatant  by ILIA. IgE protein in supernatants  of B 
cells alone  was  consistently  0.1  ng/ml. 
Discussion 
Until  recently,  the  CD8 +  T  cell  has  been  seen  as  an 
effector cell playing a fundamental role in protection against 
infection by viruses and intracellular parasites (1, 2). Indeed, 
their key functions of cytolytic activity and production of 
IFN-v and TNF-3 were considered their main activities  (1, 
2). It would be very serious for the host if the CD8 + T cells 
started to produce Th2-type cytokines. This is well demon- 
strated by the observation that Schistosoma mansoni infection, 
which induces production of Th2 cytokines, was found to 
impair the CD8 T cell cytolytic activity of the host against 
Vaccinia virus and so, delay clearance (18). Moreover, subsets 
of CD8 § T  ceils producing Th2-type cytokines have been 
isolated from patients with the highly aggressive (leproma- 
tous) form of Mycobacterium leprae infection (3). 
Clinical symptoms of a relative dominance of Th2-mediated 
responses have been described in HIV-l-infected individuals 
and include eosinophilia (18), elevation of serum IgE levels 
(19-21), and allergic manifestations (22). In some HIV-l-in- 
fected individuals, the association of eczematous dermatitis, 
sinopulmonary infections, recurrent skin lesions, hypergam- 
maglobulinemia E, and eosinophilia, has also been reported 
(8-10),  which  is  reminiscent  of  the  rare  primary  im- 
munodeficiency disorder, commonly  known as Job's, Bucldey's, 
or hyper-IgE syndrome (6, 7). These phenomena are com- 
patible with the recently proposed hypothesis that a shifting 
of CD4 + Th cells from the Thl to Th2 phenotype occurs 
in the course of HIV-1 infection and can favor the progres- 
sion of HIV infection toward the full-blown disease (23). 
The finding that the Job's-like syndrome usually develops 
in the advanced phases of the HIV-1 infection and in patients 
showing very low numbers of circulating CD4 + Th cells 
(8-10) argues, however, against this simplistic interpretation. 
Accordingly, in the two patients reported in this study, cir- 
culating CD4 + T ceils were <50/#1, suggesting that other 
cell types would be involved in the production of IL-4 and 
IL-5  responsible for so elevated serum IgE levels (>3,000 
IU/ml) and eosinophilia (>500 cdls/#l), respectively, found 
in the same patients. This view was supported by the results 
of functional analysis of circulating T  cells at donal level. 
Indeed, virtually all CD4- CD8 + T cell dories derived from 
both patients showed a dear-cut Th2-type profile of cytokine 
secretion, whereas the great majority of CD4-  CD8 + T cell 
clones obtained from the HIV-l-seronegative healthy indi- 
viduals, as well as the HIV-l-seropositive patients with simi- 
larly reduced numbers of circulating CD4 + T cells, but no 
Job's-like syndrome, had an opposite (Thl-like) profile. Thus, 
the CD8 + Th2-type ceils may account for both hyper-IgE 
(via IL-4 and, possibly, IL-13 production) and hypereosino- 
philia (via IL-5 production) seen in the HIV-l-infected pa- 
tients with the Job's-like syndrome. It is also noteworthy that 
these CD8 + T ceils exhibited markedly reduced cytolytic ac- 
tivity and were unable to produce not only IFN-% but also 
TNF-c~ and -3 (data not shown), whereas a noticeable propor- 
tion of them produced IL-10, a powerful inhibitor, together 
with IL-4, of macrophage inflammatory functions (24, 25). 
These latter alterations  may account for the undue suscepti- 
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In this respect, it is also of note that the majority of T cells 
present in the skin biopsy specimen of one of the two pa- 
tients were noncytolytic CD8 +dones  showing a Th2-1ike 
cytokine profile. These cells may be directly involved in the 
genesis of recurrent  skin infections. 
Another interesting finding emerging from this study is 
the demonstration  that  unusually high numbers  of CD4- 
CD8-  T cell clones could be generated from the peripheral 
blood  of both  patients.  Even  these  clones,  as  the  CD4- 
CD8 + ones, exhibited a Th2 profile and displayed poor or 
no cytolytic activity. Analysis of mRNA expression revealed 
that the majority of them were CD8 + T cells that have lost 
the ability to express the CD8  molecule on their  surface, 
whereas a minority failed to express mRNA for both CD4 
and CD8  molecules.  These cells  strongly resemble CD4- 
CDS- cells resulting from the switching of CD8 + cells in- 
cubated in vitro with high II,-4 concentrations (5), suggesting 
that the CD4-  CD8-, Th2-1ike,  noncytolytic T cell clones 
present in HIV-infected patients with the Job's-like syndrome 
may result from in vivo switching of CD8 + , Thl-like, cyto- 
lytic T  cells probably caused by high  IL-4 concentrations 
present  in  the microenvironment. 
The mechanisms accounting for the alterations of CD8 + 
T cells, and in particular the source of IL-4 possibly respon- 
sible for their switch to the Th2 profile, are at present un- 
clear. Recently, it has been shown that HIV-1 infection can 
induce a marked defect in macrophage production of IL-12 
(26) and IFN-oe (27), which are powerful Thlqndudng agents 
(28-30).  On the other hand, in the routine models, double 
negative  (CD4-  CD8-  TCRc~ +)  thymocytes have been 
implicated in providing  IL-4 (31),  which is critical for the 
differentiation of naive or memory CD4 + T  cells into the 
Th2 subset (16, 32, 33). Further investigation is required to 
determine whether at least a proportion of the double nega- 
tive cells  here observed represent  the equivalent  of CD4- 
CD8-  TCRc~B + cells  described in  the  mouse  (31).  The 
reason why a so dramatic  Thl  to Th2  switch occurs only 
in CD8 + T  cells from a small proportion of HIV-l-infected 
patients  (for example whether this propensity has some genetic 
cause) also needs to be elucidated. The understanding of these 
mechanisms may indeed have wider implications in designing 
new strategies for the treatment  of HIV-1 infection. 
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